Skip Menu Navigate: Select to Navigate... - Latest Blog Articles - Videos - Support Groups - News - Awards - Events Latest Blog Articles Videos Support Groups News Awards Events Sparsentan for Focal Segmental Glomerulosclerosis May 19, 2025 • 12:00 a.m. Sparsentan for Focal Segmental GlomerulosclerosisMedpage Today, May 19, 2025 UTMB’s Dr. Shikha Wadhwani joined other experts to discuss the shift toward proteinuria-based endpoints that could finally bring a targeted drug to FSGS patients. Categories Allergy Behavioral and Mental Health Cancer Cardiology Cardiovascular & Thoracic Surgery Colorectal Health COVID-19 Dermatology Ear, Nose and Throat Emergency / Urgent Care Endocrinology Eye Care Family Medicine Gastroenterology Geriatrics Gynecology Infectious Diseases Infusion Therapy Kidney Care (Nephrology) LGBTQ+ Lung Health Meet the Team Men Neurosciences Neurosurgery Occupational Therapy Oral & Maxillofacial Surgery Orthopedics Patient Stories Pediatrics Physical & Occupational Therapy Physical Therapy Plastic Surgery Pregnancy Primary Care Pulmonary & Sleep Medicine Rehabilitation Safety & Illness/Injury Prevention Sleep Apnea Sports Medicine Surgery Urogynecology & Pelvic Health Urology Vaccine Videos Weight Management Women
Sparsentan for Focal Segmental Glomerulosclerosis May 19, 2025 • 12:00 a.m. Sparsentan for Focal Segmental GlomerulosclerosisMedpage Today, May 19, 2025 UTMB’s Dr. Shikha Wadhwani joined other experts to discuss the shift toward proteinuria-based endpoints that could finally bring a targeted drug to FSGS patients.